Citron Research

As ValueAct Holdings, LP. buys a fresh stake in Rocket Companies Inc. (NYSE:RKT), Andrew Left‘s Citron Research endorses the move, calling the investment a “multi-year story.” What Happened: The co-CEO and CIO of ValueAct, Mason Morfit, added 6.728 million shares worth $81.213...

Best known for shorting stocks like GameStop, Citron Research's Andrew Left also shares long calls on stocks that are undervalued by Wall Street. Citron shared its latest stock pick Tuesday, a company it believes is misunderstood by investors. What Happened: Citron said Tuesday it is "pounding the...

Activist short seller, Andrew Left, who is the founder and editor of Citron Research has filed a petition with the U.S. Securities and Exchange Commission arguing for a stronger protection for free speech in online stock market discussions. What Happened: The petition comes amid Citron’s...

Quantum computing stocks surge to record highs in 2024, fueled by Google’s recent Willow chip announcement. Here’s an exchange-traded fund that offers investors exposure to this burgeoning sector. What Happened: Defiance Quantum ETF (NASDAQ:QTUM) is an ETF that tracks the BlueStar...

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With...

Quantum computing stocks have catapulted this year, especially after Dec. 9, when Alphabet Inc.’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google announced its latest quantum chip, Willow. However, analysts have a negative consensus rating for these stocks. What Happened: Quantum Computing Inc. stock...

Shares of Nebius Group NV (NASDAQ:NBIS) jumped 13.90% on Tuesday after Citron Research highlighted the company’s potential to become the next artificial intelligence sensation on Wall Street, citing its deep ties with NVIDIA Corp. (NASDAQ:NVDA) and perceived undervaluation compared to...

Cassava Sciences (NASDAQ:SAVA) stock is falling Monday after the company shared an update on its Phase 3 trial for a treatment for Alzheimer's disease that has been widely followed by the market. Martin Shkreli, a well-know figure in the pharmaceutical space, predicted the stock’s crash...

Investors have been hit with an increased amount of short reports from some of the most well-known names in the space, which could be due to high valuations for stocks or could be coming after the 2024 presidential election results. What Happened: Over the past three months, big names in the short...

MicroStrategy, Inc. (NASDAQ:MSTR) shares are climbing after-hours after the company announced it completed its previously announced offering of its 0% convertible senior notes due 2029.  The Details: MicroStrategy said the aggregate principal amount of the notes sold in the offering was $3...

Short seller Andrew Left is best known for being one of the prominent voices against video game retailer GameStop Corporation (NYSE:GME) during its short squeeze in 2021. The short seller now faces charges from the SEC in a case that could forever change how short reports are published. What...

Andrew Left, the renowned GameStop Corp (NYSE:GME) short-seller, has pleaded not guilty to the fraud charges brought against him by the United States. This sets the stage for a high-profile legal confrontation over his trading strategies. What Happened: Left, who is known for betting against stocks...

Famed short seller Andrew Left was charged with fraud on Friday. Federal prosecutors allege that Left manipulated stock prices for his own financial benefit. What Happened: Left, the founder of Citron Research, is accused of using his influence to manipulate stock prices in his favor, according to...

Chewy, Inc. (NYSE:CHWY) shares are trading lower Tuesday amid increased volatility after Keith Gill, also known as Roaring Kitty, disclosed a 6.6% stake in the company.  What To Know: Traders began circulating a 13F filing Sunday night which shows Gill holds roughly 9 million shares of Chewy...

Keith Gill, also known as “Roaring Kitty,” has been questioned by Citron Research, led by short seller Andrew Left, regarding his recent $200 million investment in Chewy Inc. (NYSE:CHWY). The research firm suggested that the investment may not be Gill’s own money. What...